Pappas Capital
At Pappas Capital, we are dedicated to furthering life science discoveries and bringing groundbreaking solutions to market. Pappas Capital is laser focused on t…
Thia Ventures
We are an early-stage investor in one of the most dynamic and essential fields of current human endeavor. We bring robust investor muscle to early-stage venture…
Adjuvant Capital
We see enormous opportunity in historically overlooked market segments, and we leverage our unique expertise to translate these opportunities into social and fi…
RightHill Ventures
Backed by a grant from the U.S. Economic Development Administration, RightHill Ventures works in partnership with Brown, the University of Rhode Island, and oth…
Novartis Venture Fund
Our primary focus is on the development of novel therapeutics and platforms. In our investments we look for unmet need and clinical impact, novel proprietary sc…
Trinity Innovation Bioventure Singapore
Trinity Innovation Bioventure Singapore is a licensed biomed venture capital fund focusing on innovation and value investment with deep insight and experience o…
Biovance Capital
Our expertise in biopharma and biotech investments. With decades of experience and a robust network within the biopharma and biotech industries, our team offers…
Rex Health Ventures
We are dedicated team of experienced investors who help to enable groundbreaking work by investing in and fostering companies and technologies that advance the…
Polaris Partners
We are an investment firm with more than 25 years of experience backing transformational healthcare and biotech companies. We see the world through an entrepren…
AdBio partners
AdBio partners (formerly Advent France Biotechnology) is a venture capital firm investing in early stage life sciences companies in Europe. AdBio partners’ uniq…
Panacea Innovation
Since its genesis at the University of Oxford in 2015, Panacea Innovation has partnered with some of the world’s best sci-entrepreneurs, research bodies, univer…
The Dementia Discovery Fund
The Dementia Discovery Fund (DDF) is a £250m specialist venture capital fund that invests in, and creates, new biotech companies to deliver high impact therapeu…